{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:34:43Z","timestamp":1791070483488,"version":"4.1.0"},"reference-count":239,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1517\/14622416.6.2.115","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T09:31:46Z","timestamp":1114075906000},"page":"115-138","source":"Crossref","is-referenced-by-count":100,"title":["Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2"],"prefix":"10.1080","volume":"6","author":[{"given":"Erin R","family":"Lepper","sequence":"first","affiliation":[{"name":"National Cancer Institute, Clinical Pharmacology Research Core, Building 10, Room 5A01, 9000 Rockville Pike, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees","family":"Nooter","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center, Department of Medical Oncology, 3075 EA Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Verweij","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center, Department of Medical Oncology, 3075 EA Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milin R","family":"Acharya","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Clinical Pharmacology Research Core, Building 10, Room 5A01, 9000 Rockville Pike, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Figg","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Clinical Pharmacology Research Core, Building 10, Room 5A01, 9000 Rockville Pike, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Sparreboom","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Clinical Pharmacology Research Core, Building 10, Room 5A01, 9000 Rockville Pike, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2005,11,24]]},"reference":[{"key":"e_1_3_1_3_1_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000912"},{"key":"e_1_3_1_3_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.16.1295"},{"key":"e_1_3_1_3_3_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.184901"},{"key":"e_1_3_1_3_4_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012866803188"},{"key":"e_1_3_1_3_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342010-00003"},{"key":"e_1_3_1_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90212-7"},{"key":"e_1_3_1_3_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.8.4028"},{"key":"e_1_3_1_3_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202607599"},{"key":"e_1_3_1_3_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.5.2031"},{"key":"e_1_3_1_3_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7963"},{"key":"e_1_3_1_3_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8267"},{"key":"e_1_3_1_3_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3900"},{"key":"e_1_3_1_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(02)00064-9"},{"key":"e_1_3_1_3_14_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.2.6.557"},{"key":"e_1_3_1_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.09.012"},{"key":"e_1_3_1_3_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/346362a0"},{"key":"e_1_3_1_3_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0730857100"},{"key":"e_1_3_1_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500070"},{"key":"e_1_3_1_3_19_1","first-page":"4237","volume":"59","author":"Allen","year":"1999","unstructured":"Allen JD, Brinkhuis RF, Wijnholds J, Schinkel AH: The mouse Bcrp1\/Mxr\/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res.59,4237\u20134241 (1999).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_20_1","doi-asserted-by":"crossref","unstructured":"Sparreboom A Nooter K: Does P-glycoprotein play a role in anticancer drug pharmacokinetics? Drug Resist. Updat.3 \u00a0357\u2013363 (2000).","DOI":"10.1054\/drup.2000.0164"},{"key":"e_1_3_1_3_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc706"},{"key":"e_1_3_1_3_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1224.h81602001224_1224_1232"},{"key":"e_1_3_1_3_23_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.62.070193.002125"},{"key":"e_1_3_1_3_24_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.39.1.361"},{"key":"e_1_3_1_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(01)00304-6"},{"key":"e_1_3_1_3_26_1","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1998.0326"},{"key":"e_1_3_1_3_27_1","doi-asserted-by":"publisher","DOI":"10.1006\/scbi.1997.0068"},{"key":"e_1_3_1_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(00)00153-6"},{"key":"e_1_3_1_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90141-K"},{"key":"e_1_3_1_3_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.11.2735.bloodjournal80112735"},{"key":"e_1_3_1_3_31_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.12.6924"},{"key":"e_1_3_1_3_32_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010635000879"},{"key":"e_1_3_1_3_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.4.1160"},{"key":"e_1_3_1_3_34_1","first-page":"3379","article-title":"Coadministration of oral cyclosporin A enables oral therapy with paclitaxel","volume":"5","author":"Meerum","year":"1999","unstructured":"Meerum Terwogt JM, Malingre MM, Beijnen JH et\u00a0al.: Coadministration of oral cyclosporin A enables oral therapy with paclitaxel. Clin. Cancer Res.5,3379\u20133384 (1999).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_1_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4781(01)00270-6"},{"key":"e_1_3_1_3_36_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012879205914"},{"key":"e_1_3_1_3_37_1","first-page":"1652","volume":"3","author":"Leonard","year":"2002","unstructured":"Leonard GD, Polgar O, Bates SE: ABC transporters and inhibitors: new targets, new agents. Curr. Opin. Investig. Drugs 3,1652\u20131659 (2002).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"e_1_3_1_3_38_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.8-5-411"},{"key":"e_1_3_1_3_39_1","first-page":"5337","volume":"58","author":"Allikmets","year":"1998","unstructured":"Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M: A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res.58,5337\u20135339 (1998).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_40_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15665"},{"key":"e_1_3_1_3_41_1","first-page":"8","article-title":"Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes","volume":"59","author":"Miyake","year":"1999","unstructured":"Miyake K, Mickley L, Litman T et\u00a0al.: Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res.59,8\u201313 (1999).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_42_1","first-page":"427","volume":"1","author":"Allen","year":"2002","unstructured":"Allen JD, Schinkel AH: Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP\/ABCG2). Mol. Cancer Ther.1,427\u2013434 (2002).","journal-title":"Mol. Cancer Ther."},{"key":"e_1_3_1_3_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.5.429"},{"key":"e_1_3_1_3_44_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310785200"},{"key":"e_1_3_1_3_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192276999"},{"key":"e_1_3_1_3_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0901-1028"},{"key":"e_1_3_1_3_47_1","doi-asserted-by":"publisher","DOI":"10.2144\/03356ss04"},{"key":"e_1_3_1_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(01)00308-X"},{"key":"e_1_3_1_3_49_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313599200"},{"key":"e_1_3_1_3_50_1","author":"Kolwankar","year":"2005","unstructured":"Kolwankar D, Glover DD, Ware JA, Tracy\u00a0TS: Expression and function of ABCB1 and ABCG2 in human placental tissue. Drug Metab. Dispos. (2005) (In\u00a0Press).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_1_3_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.20.1651"},{"key":"e_1_3_1_3_52_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568011043482205"},{"key":"e_1_3_1_3_53_1","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","unstructured":"Maliepaard M, Scheffer GL, Faneyte IF et\u00a0al.: Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res.61,3458\u20133464 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_54_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.1.4.22"},{"key":"e_1_3_1_3_55_1","first-page":"6447","article-title":"The breast cancer resistance protein (Bcrp1\/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine","volume":"63","author":"van","year":"2003","unstructured":"van Herwaarden AE, Jonker JW, Wagenaar\u00a0E et\u00a0al.: The breast cancer resistance protein (Bcrp1\/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res.63,6447\u20136452 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_56_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389203023380521"},{"key":"e_1_3_1_3_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.12.116"},{"key":"e_1_3_1_3_58_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-6-516"},{"key":"e_1_3_1_3_59_1","first-page":"5761","volume":"60","author":"Allen","year":"2000","unstructured":"Allen JD, Brinkhuis RF, van Deemter L, Wijnholds J, Schinkel AH: Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. Cancer Res.60,5761\u20135766 (2000).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(99)00182-2"},{"key":"e_1_3_1_3_61_1","first-page":"5850","article-title":"Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C","volume":"58","author":"Rabindran","year":"1998","unstructured":"Rabindran SK, He H, Singh M et\u00a0al.: Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res.58,5850\u20135858 (1998).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_62_1","first-page":"47","volume":"60","author":"Rabindran","year":"2000","unstructured":"Rabindran SK, Ross DD, Doyle LA, Yang\u00a0W, Greenberger LM: Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res.60, 47\u201350 (2000).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_63_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.64.3.610"},{"key":"e_1_3_1_3_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2002.tb02162.x"},{"key":"e_1_3_1_3_65_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3583"},{"key":"e_1_3_1_3_66_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301358200"},{"key":"e_1_3_1_3_67_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.7.10.1485"},{"key":"e_1_3_1_3_68_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.7.3473"},{"key":"e_1_3_1_3_69_1","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.2.1.51"},{"key":"e_1_3_1_3_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-002-8653-6"},{"key":"e_1_3_1_3_71_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.43.100901.140233"},{"key":"e_1_3_1_3_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020526"},{"key":"e_1_3_1_3_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200308000-00006"},{"key":"e_1_3_1_3_74_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.62.1.1"},{"key":"e_1_3_1_3_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.5.1749"},{"key":"e_1_3_1_3_76_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.117412"},{"key":"e_1_3_1_3_77_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6663"},{"key":"e_1_3_1_3_78_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200106000-00003"},{"key":"e_1_3_1_3_79_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.1.35"},{"key":"e_1_3_1_3_80_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350400900510"},{"key":"e_1_3_1_3_81_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.069724"},{"key":"e_1_3_1_3_82_1","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.2.1.51"},{"key":"e_1_3_1_3_83_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.322"},{"key":"e_1_3_1_3_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100380200041"},{"key":"e_1_3_1_3_85_1","first-page":"611","article-title":"C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance","volume":"1","author":"Imai","year":"2002","unstructured":"Imai Y, Nakane M, Kage K et\u00a0al.: C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther.1, 611\u2013616 (2002).","journal-title":"Mol. Cancer Ther."},{"key":"e_1_3_1_3_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200301000-00004"},{"key":"e_1_3_1_3_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0144"},{"key":"e_1_3_1_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(03)00038-1"},{"key":"e_1_3_1_3_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11669"},{"key":"e_1_3_1_3_90_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.18.212"},{"key":"e_1_3_1_3_91_1","article-title":"Effect of ABCG2 genotype and intestinal mRNA expression on the bioavailability of topotecan","volume":"22","author":"Gelderblom","year":"2004","unstructured":"Gelderblom H, Loos WJ, Sissung TM et\u00a0al.: Effect of ABCG2 genotype and intestinal mRNA expression on the bioavailability of topotecan. Proc. Am. Soc. Clin. Oncol.22\u00a0(2004).","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"e_1_3_1_3_92_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000045245.21637.d4"},{"key":"e_1_3_1_3_93_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.001628"},{"key":"e_1_3_1_3_94_1","first-page":"2463","article-title":"The Q141K single-nucleotide polymorphism impacts the transporter activity of ABCG2","volume":"45","author":"Morisaki","year":"2004","unstructured":"Morisaki K, Robey RW, Nadjem T et\u00a0al.: The Q141K single-nucleotide polymorphism impacts the transporter activity of ABCG2. Proc. Am. Assoc. Cancer Res.45, 2463 (2004).","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"e_1_3_1_3_95_1","first-page":"2294","volume":"62","author":"Allen","year":"2002","unstructured":"Allen JD, Jackson SC, Schinkel AH: A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for doxorubicin resistance. Cancer Res.62, 2294\u20132299 (2002).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_96_1","first-page":"6635","article-title":"Acquired mutations in the MXR\/BCRP\/ABCP gene alter substrate specificity in MXR\/BCRP\/ABCP-overexpressing cells","volume":"61","author":"Honjo","year":"2001","unstructured":"Honjo Y, Hrycyna CA, Yan QW et\u00a0al.: Acquired mutations in the MXR\/BCRP\/ABCP gene alter substrate specificity in MXR\/BCRP\/ABCP-overexpressing cells. Cancer Res. 61, 6635\u20136639 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601370"},{"key":"e_1_3_1_3_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3298"},{"key":"e_1_3_1_3_99_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj20030150"},{"key":"e_1_3_1_3_100_1","first-page":"5538","volume":"63","author":"Volk","year":"2003","unstructured":"Volk EL, Schneider E: Wild-type breast cancer resistance protein (BCRP\/ABCG2) is a methotrexate polyglutamate transporter. Cancer Res.63, 5538\u20135543 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_101_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.126177"},{"key":"e_1_3_1_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64794-3"},{"key":"e_1_3_1_3_103_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.112240"},{"key":"e_1_3_1_3_104_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.50002"},{"key":"e_1_3_1_3_105_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200208000-00005"},{"key":"e_1_3_1_3_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500001"},{"key":"e_1_3_1_3_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(01)01892-X"},{"key":"e_1_3_1_3_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200104000-00005"},{"key":"e_1_3_1_3_109_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.114164"},{"key":"e_1_3_1_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05579-9"},{"key":"e_1_3_1_3_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200208000-00004"},{"key":"e_1_3_1_3_112_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200404000-00005"},{"key":"e_1_3_1_3_113_1","first-page":"1351","article-title":"Genetic polymorphism at the 5\u2032 regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon","volume":"2","author":"Taniguchi","year":"2003","unstructured":"Taniguchi S, Mochida Y, Uchiumi T et\u00a0al.: Genetic polymorphism at the 5\u2032 regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon. Mol. Cancer Ther.2, 1351\u20131359 (2003).","journal-title":"Mol. Cancer Ther."},{"key":"e_1_3_1_3_114_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.129196"},{"key":"e_1_3_1_3_115_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200302000-00005"},{"key":"e_1_3_1_3_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.08.002"},{"key":"e_1_3_1_3_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200311000-00001"},{"key":"e_1_3_1_3_118_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200312000-00005"},{"key":"e_1_3_1_3_119_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.01.025"},{"key":"e_1_3_1_3_120_1","first-page":"3251","article-title":"Irinotecan pathway genotype analysis to predict pharmacokinetics","volume":"9","author":"Mathijssen","year":"2003","unstructured":"Mathijssen RHJ, Marsh S, Karlsson MO et\u00a0al.: Irinotecan pathway genotype analysis to predict pharmacokinetics. Clin. Cancer Res.9, 3251\u20133258 (2003).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_1_3_121_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:DRUG.0000026254.97350.fe"},{"key":"e_1_3_1_3_122_1","first-page":"6158","article-title":"Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir","volume":"62","author":"Bardelmeijer","year":"2002","unstructured":"Bardelmeijer HA, Ouwehand M, Buckle T et\u00a0al.: Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir. Cancer Res.62, 6158\u20136164 (2002).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_123_1","first-page":"2598","volume":"6","author":"van","year":"2000","unstructured":"van Zuylen L, Verweij J, Nooter K, Brouwer\u00a0E, Stoter G, Sparreboom A: Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans. Clin. Cancer Res.6, 2598\u20132603 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_1_3_124_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-001-0420-4"},{"key":"e_1_3_1_3_125_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.177"},{"key":"e_1_3_1_3_126_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.7.823"},{"key":"e_1_3_1_3_127_1","doi-asserted-by":"publisher","DOI":"10.1080\/10245330310001638974"},{"key":"e_1_3_1_3_128_1","first-page":"4955","article-title":"MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients","volume":"62","author":"Illmer","year":"2002","unstructured":"Illmer T, Schuler US, Thiede C et\u00a0al.: MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res.62, 4955\u20134962 (2002).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_129_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00228.x"},{"key":"e_1_3_1_3_130_1","first-page":"1117","article-title":"Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer","volume":"22","author":"Kafka","year":"2003","unstructured":"Kafka A, Sauer G, Jaeger C et\u00a0al.: Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. Int. J. Oncol.22, 1117\u20131121 (2003).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_1_3_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000019412.87412.BC"},{"key":"e_1_3_1_3_132_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021986"},{"key":"e_1_3_1_3_133_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50010"},{"key":"e_1_3_1_3_134_1","doi-asserted-by":"publisher","DOI":"10.1086\/379927"},{"key":"e_1_3_1_3_135_1","volume":"126","author":"Glas","year":"2004","unstructured":"Glas J, Torok HP, Schiemann U, Folwaczny\u00a0C: MDR1 gene polymorphism in ulcerative colitis. Gastroenterology126,\u00a0367 (2004).","journal-title":"Gastroenterology"},{"key":"e_1_3_1_3_136_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364123"},{"key":"e_1_3_1_3_137_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.08.044"},{"key":"e_1_3_1_3_138_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200305000-00004"},{"key":"e_1_3_1_3_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.09.046"},{"key":"e_1_3_1_3_140_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200311000-00003"},{"key":"e_1_3_1_3_141_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200311000-00002"},{"key":"e_1_3_1_3_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07276-8"},{"key":"e_1_3_1_3_143_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301240-00010"},{"key":"e_1_3_1_3_144_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200311010-00006"},{"key":"e_1_3_1_3_145_1","doi-asserted-by":"publisher","DOI":"10.1086\/380134"},{"key":"e_1_3_1_3_146_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307250-00016"},{"key":"e_1_3_1_3_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.03.003"},{"key":"e_1_3_1_3_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)00151-X"},{"key":"e_1_3_1_3_149_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1398"},{"key":"e_1_3_1_3_150_1","first-page":"4717","volume":"6","author":"de","year":"1986","unstructured":"de Bruijn MH, Van de Bliek AM, Biedler\u00a0JL, Borst P: Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines. Mol. Cell. Biol.6, 4717\u20134722 (1986).","journal-title":"Mol. Cell. Biol."},{"key":"e_1_3_1_3_151_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199702000-00004"},{"key":"e_1_3_1_3_152_1","first-page":"4413","volume":"43","author":"Kartner","year":"1983","unstructured":"Kartner N, Shales M, Riordan JR, Ling V: Daunorubicin-resistant Chinese hamster ovary cells expressing resistance and a cell-surface P-glycoprotein. Cancer Res.43,\u00a04413\u20134419 (1983).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(02)00359-2"},{"key":"e_1_3_1_3_154_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.4.288"},{"key":"e_1_3_1_3_155_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199909000-00005"},{"key":"e_1_3_1_3_156_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.9.3004"},{"key":"e_1_3_1_3_157_1","first-page":"1365","article-title":"The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel","volume":"6","author":"van Zuylen","year":"2000","unstructured":"van Zuylen L, Sparreboom A, van der Gaast A et\u00a0al.: The orally administered P-glycoprotein inhibitor R101933 does not alter the plasma pharmacokinetics of docetaxel. Clin. Cancer Res.6, 1365\u20131371 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_1_3_158_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.12.4486"},{"key":"e_1_3_1_3_159_1","first-page":"4226","article-title":"In\u00a0vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ-PSC 833","volume":"51","author":"Boesch","year":"1991","unstructured":"Boesch D, Gaveriaux C, Jachez B, Pourtier-Manzanedo A, Bollinger P, Loor F: In\u00a0vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ-PSC 833. Cancer Res. 51, 4226\u20134233 (1991).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(02)00095-9"},{"key":"e_1_3_1_3_161_1","first-page":"4171","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979","volume":"56","author":"Dantzig","year":"1996","unstructured":"Dantzig AH, Shepard RL, Cao J et\u00a0al.: Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res.56, 4171\u20134179 (1996).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_162_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.58"},{"key":"e_1_3_1_3_163_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199909100-00004"},{"key":"e_1_3_1_3_164_1","first-page":"2729","volume":"49","author":"Schurr","year":"1989","unstructured":"Schurr E, Raymond M, Bell JC, Gros P: Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA. Cancer Res.49, 2729\u20132733 (1989).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_165_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702807"},{"key":"e_1_3_1_3_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)71586-X"},{"key":"e_1_3_1_3_167_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01212879"},{"key":"e_1_3_1_3_168_1","first-page":"2422","volume":"49","author":"Wolverton","year":"1987","unstructured":"Wolverton JS, Danks MK, Schmidt CA, Beck WT: Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells. Cancer Res.49, 2422\u20132426 (1987).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_169_1","first-page":"2268","volume":"52","author":"Hendricks","year":"1992","unstructured":"Hendricks CB, Rowinsky EK, Grochow LB, Donehower RC, Kaufmann SH: Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue. Cancer Res.52, 2268\u20132278 (1992).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_170_1","first-page":"6288","volume":"47","author":"Horton","year":"1987","unstructured":"Horton JK, Houghton PJ, Houghton JA: Reciprocal cross-resistance in human rhabdomyosarcomas selected in\u00a0vivo for primary resistance to vincristine and L-phenylalanine mustard. Cancer Res.47,\u00a06288\u20136293 (1987).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_171_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb07037.x"},{"key":"e_1_3_1_3_172_1","first-page":"3228","article-title":"Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin","volume":"63","author":"Rajendra","year":"2003","unstructured":"Rajendra R, Gounder MK, Saleem A et\u00a0al.: Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin. Cancer Res. 63, 3228\u20133233 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_173_1","first-page":"739","article-title":"The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux","volume":"61","author":"Erlichman","year":"2001","unstructured":"Erlichman C, Boerner SA, Hallgren CG et\u00a0al.: The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux. Cancer Res. 61, 739\u2013748 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_174_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0914-3"},{"key":"e_1_3_1_3_175_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.063149"},{"key":"e_1_3_1_3_176_1","first-page":"105","volume":"2","author":"Sugimoto","year":"2003","unstructured":"Sugimoto Y, Tsukahara S, Imai Y, Ueda K, Tsuruo T: Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists. Mol. Cancer Ther.2, 105\u2013112 (2003).","journal-title":"Mol. Cancer Ther."},{"key":"e_1_3_1_3_177_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200006000-00005"},{"key":"e_1_3_1_3_178_1","first-page":"827","article-title":"RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response","volume":"9","author":"Burger","year":"2003","unstructured":"Burger H, Foekens JA, Look MP et\u00a0al.: RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin. Cancer Res.9, 827\u2013836 (2003).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_1_3_179_1","first-page":"4048","article-title":"Transport of methotrexate, methotrexate polyglutamates, and 17\u03b2-estradiol 17-(\u03b2-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport","volume":"63","author":"Chen","year":"2003","unstructured":"Chen ZS, Robey RW, Belinsky MG et\u00a0al.: Transport of methotrexate, methotrexate polyglutamates, and 17\u03b2-estradiol 17-(\u03b2-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res.63, 4048\u20134054 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_180_1","first-page":"2519","volume":"23","author":"Yang","year":"2003","unstructured":"Yang CH, Chen YC, Kuo ML: Novobiocin sensitizes BCRP\/MXR\/ABCP overexpressing topotecan-resistant human breast carcinoma cells to topotecan and mitoxantrone. Anti-Cancer Res. 23, 2519\u20132523 (2003).","journal-title":"Anti-Cancer Res."},{"key":"e_1_3_1_3_181_1","first-page":"145","article-title":"Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr\/BCrp\/ABCP1), in flavopiridol-resistant human breast cancer cells","volume":"7","author":"Robey","year":"2001","unstructured":"Robey RW, Medina-Perez WY, Nishiyama K et\u00a0al.: Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr\/BCrp\/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin. Cancer Res.7, 145\u2013152 (2001).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_1_3_182_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg121"},{"key":"e_1_3_1_3_183_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3344"},{"key":"e_1_3_1_3_184_1","first-page":"2827","article-title":"Identification of breast cancer resistant protein\/mitoxantrone resistance\/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure","volume":"61","author":"Komatani","year":"2001","unstructured":"Komatani H, Kotani H, Hara Y et\u00a0al.: Identification of breast cancer resistant protein\/mitoxantrone resistance\/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure. Cancer Res.61,\u00a02827\u20132832 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_185_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.065342"},{"key":"e_1_3_1_3_186_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-003-0745-2"},{"key":"e_1_3_1_3_187_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj20030886"},{"key":"e_1_3_1_3_188_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.4267"},{"key":"e_1_3_1_3_189_1","first-page":"4559","article-title":"Overexpression of the BCRP\/MXR\/ABCP gene in a topotecan-selected ovarian tumor cell line","volume":"59","author":"Maliepaard","year":"1999","unstructured":"Maliepaard M, van Gastelen MA, de Jong LA et\u00a0al.: Overexpression of the BCRP\/MXR\/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res.59, 4559\u20134563 (1999).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_190_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.006494"},{"key":"e_1_3_1_3_191_1","first-page":"293","article-title":"MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia","volume":"11","author":"Drescher","year":"2001","unstructured":"Drescher S, van der Kuip H, Schaffeler E et\u00a0al.: MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. Pharmacogenetics11, 293\u2013298 (2001).","journal-title":"Pharmacogenetics"},{"key":"e_1_3_1_3_192_1","first-page":"5461","article-title":"Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins","volume":"61","author":"Diah","year":"2001","unstructured":"Diah SK, Smitherman PK, Aldridge J et\u00a0al.: Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Res.61, 5461\u20135467 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_1_3_193_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2003.00163.x"},{"key":"e_1_3_1_3_194_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01133.x"},{"key":"e_1_3_1_3_195_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.127739"},{"key":"e_1_3_1_3_196_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.122055"},{"key":"e_1_3_1_3_197_1","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.123.773"},{"key":"e_1_3_1_3_198_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.25.1356"},{"key":"e_1_3_1_3_199_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200406000-00007"},{"key":"e_1_3_1_3_200_1","first-page":"1137","article-title":"Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene","volume":"297","author":"Tanabe","year":"2001","unstructured":"Tanabe M, Ieiri I, Nagata N et\u00a0al.: Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther.297, 1137\u20131143 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_1_3_201_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200405000-00006"},{"key":"e_1_3_1_3_202_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-003-0105-4"},{"key":"e_1_3_1_3_203_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-004-0823-0"},{"key":"e_1_3_1_3_204_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh319"},{"key":"e_1_3_1_3_205_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-2105"},{"key":"e_1_3_1_3_206_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh298"},{"key":"e_1_3_1_3_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.05.007"},{"key":"e_1_3_1_3_208_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(01)17221-8"},{"key":"e_1_3_1_3_209_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012244520615"},{"key":"e_1_3_1_3_210_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01691.x"},{"key":"e_1_3_1_3_211_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020433422259"},{"key":"e_1_3_1_3_212_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0567-5"},{"key":"e_1_3_1_3_213_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.8.979.32881"},{"key":"e_1_3_1_3_214_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023282312757"},{"key":"e_1_3_1_3_215_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.6.1048"},{"key":"e_1_3_1_3_216_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200206000-00012"},{"key":"e_1_3_1_3_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00168-1"},{"key":"e_1_3_1_3_218_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003257222"},{"key":"e_1_3_1_3_219_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003253617"},{"key":"e_1_3_1_3_220_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200403000-00002"},{"key":"e_1_3_1_3_221_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.01.009"},{"key":"e_1_3_1_3_222_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000130981.55654.78"},{"key":"e_1_3_1_3_223_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.08.022"},{"key":"e_1_3_1_3_224_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200212150-00002"},{"key":"e_1_3_1_3_225_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200208270-00024"},{"key":"e_1_3_1_3_226_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00077.x"},{"key":"e_1_3_1_3_227_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000073901.94759.36"},{"key":"e_1_3_1_3_228_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003262108"},{"key":"e_1_3_1_3_229_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02182.x"},{"key":"e_1_3_1_3_230_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000137789.58694.B4"},{"key":"e_1_3_1_3_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)90568-6"},{"key":"e_1_3_1_3_232_1","first-page":"2391","article-title":"Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study","volume":"18","author":"Haas","year":"2004","unstructured":"Haas DW, Ribaudo HJ, Kim RB et\u00a0al.: Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS18,\u00a02391\u20132400 (2004).","journal-title":"AIDS"},{"key":"e_1_3_1_3_233_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01591.x"},{"key":"e_1_3_1_3_234_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00234-0"},{"key":"e_1_3_1_3_235_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500099"},{"key":"e_1_3_1_3_236_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500025"},{"key":"e_1_3_1_3_237_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(02)00426-3"},{"key":"e_1_3_1_3_238_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500220"},{"key":"e_1_3_2_2_1","unstructured":"www.gene.ucl.ac.uk\/nomenclature\/genefamily\/ abc.html Human ABC transporter genes (accessed February 2005)."}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14622416.6.2.115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:51:57Z","timestamp":1715957517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14622416.6.2.115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":239,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1517\/14622416.6.2.115"],"URL":"https:\/\/doi.org\/10.1517\/14622416.6.2.115","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}